BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3381006)

  • 21. NTP Toxicology and Carcinogenesis Studies of Benzyl Acetate (CAS No. 140-11-4) in F344/N Rats and B6C3F1 Mice Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 431():1-285. PubMed ID: 12616300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NTP Toxicology and Carcinogenesis Studies of Polybrominated Biphenyls (CAS No. 67774-32-7)(Firemaster FF-1(R)) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 398():1-235. PubMed ID: 12637961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminophenyl ether compound (YM-95831), a new hypolipidemic agent with a high density lipoprotein elevating activity in rats.
    Ohata I; Sakamoto N; Nitatori R; Maeno H
    Arzneimittelforschung; 1983; 33(2):237-41. PubMed ID: 6682662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of clofibrate, silybin, safflower oil and lamindran on liver peroxisome proliferation and enzyme activities in rats].
    Wu SG; Shen YA; Zheng Z; Long K
    Zhongguo Yao Li Xue Bao; 1986 May; 7(3):283-4. PubMed ID: 2954381
    [No Abstract]   [Full Text] [Related]  

  • 25. NTP technical report on the toxicity studies of malachite green chloride and leucomalachite green (CAS Nos. 569-64-2 and 129-73-7) administered in feed to F344/N rats and B6C3F1 mice.
    Culp SJ
    Toxic Rep Ser; 2004 Jun; (71):1-F10. PubMed ID: 15213768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Euglycemic and hypolipidemic activity of PAT5A: a unique thiazolidinedione with weak peroxisome proliferator activated receptor gamma activity.
    Vikramadithyan RK; Chakrabarti R; Misra P; Premkumar M; Kumar SK; Rao CS; Ghosh A; Reddy KN; Uma C; Rajagopalan R
    Metabolism; 2000 Nov; 49(11):1417-23. PubMed ID: 11092504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of dietary fat on the effect of endotoxin on murine hepatic peroxisomes.
    DeLamatre JG; Schilleci JT; Hanson LH
    Hepatology; 1996 Sep; 24(3):592-5. PubMed ID: 8781330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator.
    Rao MS; Lalwani ND; Watanabe TK; Reddy JK
    Cancer Res; 1984 Mar; 44(3):1072-6. PubMed ID: 6692393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitogenic effect in mouse liver induced by a hypolipidemic drug, nafenopin.
    Moody DE; Rao MS; Reddy JK
    Virchows Arch B Cell Pathol; 1977 Apr; 23(4):291-6. PubMed ID: 404752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Placental transfer of the hypolipidemic drug, clofibrate, induces CYP4A expression in 18.5-day fetal rats.
    Simpson AE; Brammar WJ; Pratten MK; Cockcroft N; Elcombe CR
    Drug Metab Dispos; 1996 May; 24(5):547-54. PubMed ID: 8723735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferators activate Kupffer cells in vivo.
    Bojes HK; Thurman RG
    Cancer Res; 1996 Jan; 56(1):1-4. PubMed ID: 8548746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome enzyme modification and oxidative stress in rat by hypolipidemic and antiinflammatory drugs.
    Rivero A; Monreal JI; Gil MJ
    Rev Esp Fisiol; 1994 Dec; 50(4):259-68. PubMed ID: 7754169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic catalase is not essential for the hypolipidemic action of peroxisome proliferators.
    Reddy JK; Moody DE; Azarnoff DL; Rao MS
    Proc Soc Exp Biol Med; 1977 Apr; 154(4):483-7. PubMed ID: 859854
    [No Abstract]   [Full Text] [Related]  

  • 38. The peroxisome proliferation-associated polypeptide in rat liver.
    Reddy JK; Kumar NS
    Biochem Biophys Res Commun; 1977 Aug; 77(3):824-9. PubMed ID: 901515
    [No Abstract]   [Full Text] [Related]  

  • 39. Decreased plasma esterase-1 activity in rats fed a high-phosphorus diet.
    van Lith HA; Haller M; Ritskes-Hoitinga J; Beynen AC
    Int J Vitam Nutr Res; 1991; 61(1):98-9. PubMed ID: 1856053
    [No Abstract]   [Full Text] [Related]  

  • 40. Possible properties of microbodies (peroxisomes). Microbody proliferation and hypolipidemic drugs.
    Reddy JK
    J Histochem Cytochem; 1973 Nov; 21(11):967-71. PubMed ID: 4587529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.